CY1117420T1 -
A crystalline form of its (R) -7-chloro-N- (quinuclidin-3-yl) benzene [B] thiophene-2-carboxamide monohydrate hydrochloride
- Google Patents
A crystalline form of its (R) -7-chloro-N- (quinuclidin-3-yl) benzene [B] thiophene-2-carboxamide monohydrate hydrochloride
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11721413.0Aexternal-prioritypatent/EP2571874B1/en
Application filed by Forum Pharmaceuticals Inc.filedCriticalForum Pharmaceuticals Inc.
Publication of CY1117420T1publicationCriticalpatent/CY1117420T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Κρυσταλλικές Μορφές I και II του μονοένυδρου υδροχλωριδίου του (R)-7-χλωρο-Ν-(κινουκλιδιν-3-υλο)βενζο[b]θειοφαινο-2-καρβοξαμιδίου και συνθέσεις, μέθοδοι παρασκευής και θεραπευτικές χρήσεις αυτών περιγράφονται.Crystalline Forms I and II of (R) -7-chloro-N- (quinuclidin-3-yl) benzo [b] thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of preparation and therapeutic uses thereof are described.
CY20161100343T2010-05-172016-04-26
A crystalline form of its (R) -7-chloro-N- (quinuclidin-3-yl) benzene [B] thiophene-2-carboxamide monohydrate hydrochloride
CY1117420T1
(en)
Compounds derived from carbocyclyl / heterocyclyl-pyridin-2-yl-urea, bacterial topoisomerase iv inhibitors; pharmaceutical composition; and its use for the treatment of bacterial infections
compound, pharmaceutical composition, use of the compound or a pharmaceutically acceptable salt thereof, and method of treating an hcv infected patient
Active ingredient combinations comprising dihydrofuranone derivatives and abamectin, mixture/beneficial species combinations and kit comprising same and uses thereof